Cowen Inc’s Ligand Pharmaceuticals LGND Stock Holding History

Cowen Inc’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,427	Closed	-$216K	–	359
2015 Q2	$216K	Buy	+3,427	New	+$187K	0.01%	349

Other funds holding LGND

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cowen Inc's LGND Position: Q3 2015 in Review

Cowen Inc sold out of Ligand Pharmaceuticals (LGND) in Q3 2015, closing a stake of 3,427 shares — an estimated $216K sold.

Cowen Inc first reported a position in LGND in Q2 2015 and held it in 1 quarter. The position peaked at $216K in Q2 2015. 203 funds tracked by Wall St. Rank hold LGND as of Q3 2015.

Cowen Inc reported no remaining Ligand Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Cowen Inc sold 3,427 Ligand Pharmaceuticals shares in Q3 2015, an estimated $216K.
Cowen Inc first reported a position in Ligand Pharmaceuticals in Q2 2015 and held it in 1 quarter.
Cowen Inc's Ligand Pharmaceuticals position peaked at $216K in Q2 2015.
203 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2015.

Based on Cowen Inc's 13F filing for Q3 2015, filed 13 Nov 2015.